Menu
silhouette soft, fadenlifting, fadenlifting vorher nachher, fadenlifting kosten, fadenlifting erfahrungen, fadenlifting vorher nachher bilder, collagen fadenlifting, fadenlifting augen, fadenlifting nach 3 wochen,

Accessibility

The Site is brought to you by Sinclair Pharma Ltd (Sinclair). Our registered office is 30-32 Whitfield Street, Whitfield Court, London, W1T 2RQ with company registration number 03816616.

Sinclair recognises the importance of providing a website that is accessible to all user groups including people with disabilities such as blindness and low vision, deafness and hearing loss, learning disabilities, cognitive limitations, limited movement, speech disabilities, photosensitivity and combinations of these.

Sinclair has designed the Site with accessibility in mind, following the guidelines laid down by the W3C Web Accessibility Initiative (WAI).

Web Content Accessibility Guidelines (WCAG) 2.0 covers a wide range of recommendations for making web content more accessible to a wider range of people with disabilities and will also often make web content more usable to users in general.

The 12 accessibility guidelines are:

  • Provide text alternatives for non-text content.
  • Provide captions and alternatives for audio and video content.
  • Make content adaptable; and make it available to assistive technologies.
  • Use sufficient contrast to make things easy to see and hear.
  • Make all functionality keyboard accessible.
  • Give users enough time to read and use content.
  • Do not use content that causes seizures.
  • Help users navigate and find content.
  • Make text readable and understandable.
  • Make content appear and operate in predictable ways.
  • Help users avoid and correct mistakes.
  • Maximize compatibility with current and future technologies.
  • There are three levels of conformance to the accessibility guidelines: A (lowest), AA, and AAA (highest) and our aim is to conform to AA Level. However these are guidelines only and in some instances it is not practical to conform exactly to all checkpoints. If you have any queries about the accessibility of this website please contact enquiries@sinclairpharma.com

Indication:

The EU approved intended use is: Silhouette Soft is a resorbable sterile implantable single-use device intended to be used in adult patients for facial and neck reconstruction in the treatment of facial morphological asymmetry and ptosis, including but not limited to:

Indication:

The EU approved intended use is: Silhouette Soft is a resorbable sterile implantable single-use device intended to be used in adult patients for facial and neck reconstruction in the treatment of facial morphological asymmetry and ptosis, including but not limited to:

The effects of facial ptosis or paralysis (e.g. Bell’s palsy, benign or malignant tumours, iatrogenic injury, Varicella-zoster virus associated facial palsy, trauma, and congenital palsy).

Morphological asymmetry (e.g. congenital anomalies, trauma to the face or the temporomandibular joint).

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include infection, minimal acute inflammatory tissue reaction, pain (which may be temporary or persistent in nature), swelling and oedema, transient haematoma or bruising and transient rippling or dimple formation.

Other potential adverse events include ecchymosis, sensory/motor nerve injury, asymmetry, banding, thread migrations and palpable thread ends/knots. Material sensitivity/allergic reactions in patients following surgery may occur. The onset of any adverse event must be reported immediately. Please contact the local Sinclair representative or authorised Silhouette distributor. Alternatively send the details to quality@sinclairpharma.com

For a full list of contraindications, warnings, and precautions for this product please visit http://www.sinclairpharma.com/eifu/ for a copy of the Product Instructions for Use.